Navigation Links
Scientists Explore Ways to Lure Viruses to Their Death

There are only a few basic ways to fight viruses. A vaccine can prime the immune system to attack them as soon as they invade the body//. If a virus manages to establish itself, a doctor may be able to prescribe a drug to slow down its spread. And if all else fails, a doctor may quarantine a patient to head off an epidemic.

Now some scientists are exploring a fundamentally different strategy to fight viruses. They want to wipe them out by luring them to their destruction, like mice to mousetraps.

Viruses invade a cell by latching onto certain proteins on its surface. Once attached, they can slip inside the cell and manipulate it into making new copies of themselves. But viruses cannot infect red blood cells. Unlike most other cells in the body, as red blood cells develop in bone marrow they lose their DNA. If a virus ends up inside a red blood cell, there are no genes it can hijack to replicate itself.

“It occurred to us that if a virus bound to a red blood cell, that was a dead end,” said Dr. Robert W. Finberg, a professor at the University of Massachusetts Medical School.

Dr. Finberg and his colleagues decided to turn red blood cells into virus traps. They would bait their traps with a surface protein called CAR. A virus called coxsackie virus B attaches to CAR, using it to invade cells in the pancreas. The new viruses produced by the pancreas stream out through the bloodstream, attaching to CAR proteins in the cells of other organs like the heart and the liver.

The researchers engineered mice to produce CAR on their red blood cells and then compared how they fared against coxsackie virus B compared with normal mice. In the engineered mice, viruses reached only 1 percent to 10 percent of the levels they reached in many organs in normal mice. The normal mice all died within a week of infection. The engineered mice tended to live longer, and after two weeks a third of them were still alive.

Dr. Finberg’s experiments show that virus traps have some promise, but they do not reveal exactly why they failed to eradicate the virus. “What is the threshold for these traps so that they will force the viruses into extinction?” asks Paul E. Turner, an evolutionary biologist at Yale. Dr. Turner and his colleagues are trying to find the answer, but instead of studying mice, they are studying bacteria.

The researchers study a virus called phi-6, which normally infects a species of bacteria called Pseudomonas phaseolica, a microbe that lives on plants. The bacteria grab onto plants with long sticky hairs, which they retract to bring themselves close to their hosts. The phi-6 virus attaches to proteins on the hairs, and when the bacteria retract, the viruses can invade them.

A mutant form of Pseudomonas grows a lot of extra hairs, which make it an attractive target for viruses. But it cannot retract its hairs, so the viruses cannot get inside it to replicate. Dr. Turner and his colleagues reasoned that these mutants might act as traps for phi-6 viruses, luring them into a dead end.

Because Dr. Turner’s team study bacteria instead of mice, they can run many more experiments to discover the ecological rules of viral traps. Dr. Finberg’s team needed a year to design and raise a handful of mice with viral traps. Bacteria can breed by the billions in a few hours.

Dr. Turner and his colleagues created a mathematical model to predict how phi-6 would fair if they mixed viral traps into a colony of normal Pseudomonas hosts. They predicted that the more virus traps the scientists added, the more the virus population would shrink. Above a threshold of traps, the viruses would not be able replace their lost numbers, and they would disappear completely.

To test the model, the scientists mixed normal bacteria with different levels of mutant traps and then infected them with viruses. After letting the viruses replicate, the sci entists took a small sample to start a new colony. They discovered there was indeed a trap threshold above which the virus population could not survive. Above that threshold, the viruses disappeared by the time the scientists started the third round of colonies.

Dr. Turner and his colleagues reported their results this month in the journal Ecology Letters.

Now Dr. Turner and his colleagues are using what they have learned with bacteria to study HIV, the virus that causes AIDS. Normally, HIV infects immune cells called CD4 T cells. Dr. Turner’s team is building red blood cells studded with CD4 proteins on their surface, in the hope of building an HIV trap.

“Once we have those, we can test whether they truly attract HIV,” Dr. Turner said. “And then we can set up experiments like the ones we’ve done with bacteria.”

Source-Bio-Bio Technlogy
SRM
'"/>




Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies ... to help with process innovation in drug formulation and manufacturing. CoreRx offers ... state-of-the-art analytical equipment in support of their development and manufacturing goals. , ...
(Date:4/25/2017)... Plains, NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is ... the treatment of acute or chronic problems, I focus on preventative care with all my ... If you have any questions, always feel free to contact my office and my trained ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement ... quarterback position. The former overall number one pick in the 2001 NFL Draft, to ... holds the record for the most career rushing yards by a quarterback (6,109) and ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner ... Education Research Award. The award honors scholars exemplary in their capacity to communicate ... who has demonstrated the capacity to deepen the public’s understanding and appreciation of ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
(Date:4/18/2017)... SAN DIEGO , April 18, 2017  Astute ... previewed a case series to be presented at the ... , which begins today and continues through April 22. ... and IGFBP-7 , used to assess risk for acute ... acute decompensated heart failure (ADHF). Elevated ...
Breaking Medicine Technology: